SEB Asset Management’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.1M Hold
41,179
– – 0.06% 262
2026
Q2
$11.7M Sell
41,179
-14,899
-27% -$4.39M 0.04% 310
2026
Q1
$16.7M Buy
+56,078
New +$18.2M 0.07% 229

Other funds holding ONC

SEB Asset Management's ONC Position: Q3 2026 in Review

SEB Asset Management held its BeOne Medicines (ONC) position steady in Q3 2026 at 41,179 shares worth $15.1M. The position accounts for 0.06% of the portfolio, ranked #262.

SEB Asset Management first reported a position in ONC in Q1 2026 and has held it in 3 quarters since. The position peaked at $16.7M in Q1 2026. 323 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • SEB Asset Management held 41,179 shares of BeOne Medicines worth $15.1M as of Q3 2026.
  • SEB Asset Management left its BeOne Medicines share count unchanged in Q3 2026.
  • BeOne Medicines made up 0.06% of SEB Asset Management's portfolio in Q3 2026, its #262 holding.
  • SEB Asset Management first reported a position in BeOne Medicines in Q1 2026 and has held it in 3 quarters since.
  • SEB Asset Management's BeOne Medicines position peaked at $16.7M in Q1 2026.
  • 323 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.